Spire Healthcare Group (LON:SPI) Stock Price Up 14.1% - Should You Buy?

Key Points

• Spire Healthcare Group's shares surged by 14.1%, reaching a trading high of GBX 256.50 ($3.46), with an exceptional trading volume of nearly 9.75 million shares.
• Analysts have mixed views on Spire Healthcare Group, with JPMorgan lowering its price target to GBX 303 while Berenberg maintained a "buy" rating with a target of GBX 280.
• The company reported GBX 4.10 earnings per share in its last quarterly earnings, and analysts expect approximately 15.66 earnings per share for the current fiscal year.

Spire Healthcare Group plc (LON:SPI - Get Free Report) shares shot up 14.1% on Friday . The company traded as high as GBX 256.50 ($3.46) and last traded at GBX 247 ($3.33). 9,747,062 shares traded hands during trading, an increase of 563% from the average session volume of 1,469,073 shares. The stock had previously closed at GBX 216.50 ($2.92).

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on the stock. Berenberg Bank reaffirmed a "buy" rating and issued a GBX 280 target price on shares of Spire Healthcare Group in a report on Thursday, July 31st. JPMorgan Chase & Co. dropped their price objective on shares of Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating on the stock in a research note on Tuesday, August 5th. Three investment analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus price target of GBX 294.33.

Spire Healthcare Group Trading Down 4.4%

The stock has a market cap of £949.70 million, a PE ratio of 5,131.02, a P/E/G ratio of 1.06 and a beta of 0.96. The company has a quick ratio of 0.74, a current ratio of 0.70 and a debt-to-equity ratio of 62.25. The business's fifty day moving average is GBX 218.75 and its 200 day moving average is GBX 203.55.

Spire Healthcare Group (LON:SPI - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The company reported GBX 4.10 EPS for the quarter. Spire Healthcare Group had a net margin of 1.96% and a return on equity of 3.82%. As a group, analysts predict that Spire Healthcare Group plc will post 15.6634747 earnings per share for the current year.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.